Literature DB >> 23979084

The transfer of drugs and therapeutics into human breast milk: an update on selected topics.

Hari Cheryl Sachs.   

Abstract

Many mothers are inappropriately advised to discontinue breastfeeding or avoid taking essential medications because of fears of adverse effects on their infants. This cautious approach may be unnecessary in many cases, because only a small proportion of medications are contraindicated in breastfeeding mothers or associated with adverse effects on their infants. Information to inform physicians about the extent of excretion for a particular drug into human milk is needed but may not be available. Previous statements on this topic from the American Academy of Pediatrics provided physicians with data concerning the known excretion of specific medications into breast milk. More current and comprehensive information is now available on the Internet, as well as an application for mobile devices, at LactMed (http://toxnet.nlm.nih.gov). Therefore, with the exception of radioactive compounds requiring temporary cessation of breastfeeding, the reader will be referred to LactMed to obtain the most current data on an individual medication. This report discusses several topics of interest surrounding lactation, such as the use of psychotropic therapies, drugs to treat substance abuse, narcotics, galactagogues, and herbal products, as well as immunization of breastfeeding women. A discussion regarding the global implications of maternal medications and lactation in the developing world is beyond the scope of this report. The World Health Organization offers several programs and resources that address the importance of breastfeeding (see http://www.who.int/topics/breastfeeding/en/).

Entities:  

Keywords:  human milk

Mesh:

Substances:

Year:  2013        PMID: 23979084     DOI: 10.1542/peds.2013-1985

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  50 in total

1.  The Difficulties in Antihypertensive Drug Prescription During Lactation: Is the Information Consistent?

Authors:  Sofia Colaceci; Angela Giusti; Elise Merrill Chapin; Micaela Notarangelo; Alessia De Angelis; Ercole Vellone; Rosaria Alvaro
Journal:  Breastfeed Med       Date:  2015-11-13       Impact factor: 1.817

Review 2.  ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.

Authors:  Sarah Reece-Stremtan; Kathleen A Marinelli
Journal:  Breastfeed Med       Date:  2015-04       Impact factor: 1.817

3.  A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.

Authors:  Etienne Weisskopf; Monia Guidi; Céline J Fischer; Myriam Bickle Graz; Etienne Beaufils; Kim An Nguyen; Mathilde Morisod Harari; Sylvie Rouiller; Sophie Rothenburger; Pascal Gaucherand; Behrouz Kassai-Koupai; Cristina Borradori Tolsa; Manuella Epiney; Jean-François Tolsa; Yvan Vial; Jean-Michel Hascoët; Olivier Claris; Chin B Eap; Alice Panchaud; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2020-04-14       Impact factor: 4.335

Review 4.  Maternity Care for Pregnant Women with Opioid Use Disorder: A Review.

Authors:  Abigail H Rizk; Sara E Simonsen; Leissa Roberts; Lisa Taylor-Swanson; Jennifer Berkowicz Lemoine; Marcela Smid
Journal:  J Midwifery Womens Health       Date:  2019-08-12       Impact factor: 2.388

Review 5.  Sertraline and breastfeeding: review and meta-analysis.

Authors:  Emily Pinheiro; Debra L Bogen; Denada Hoxha; Jody D Ciolino; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2015-01-15       Impact factor: 3.633

6.  Implementation and Organization of a Perioperative Lactation Program: A Descriptive Study.

Authors:  Elizabeth F Rieth; Kara M Barnett; Jennifer A Simon
Journal:  Breastfeed Med       Date:  2017-12-22       Impact factor: 1.817

Review 7.  Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.

Authors:  J Wang; T Johnson; L Sahin; M S Tassinari; P O Anderson; T E Baker; C Bucci-Rechtweg; G J Burckart; C D Chambers; T W Hale; D Johnson-Lyles; R M Nelson; C Nguyen; D Pica-Branco; Z Ren; H Sachs; J Sauberan; A Zajicek; S Ito; L P Yao
Journal:  Clin Pharmacol Ther       Date:  2017-06       Impact factor: 6.875

8.  ABM Clinical Protocol #5: Peripartum breastfeeding management for the healthy mother and infant at term, revision 2013.

Authors:  Allison V Holmes; Angela Yerdon McLeod; Maya Bunik
Journal:  Breastfeed Med       Date:  2013-12       Impact factor: 1.817

Review 9.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

10.  Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk.

Authors:  Joshua Gini; Sujan Dilly Penchala; Alieu Amara; Elizabeth Challenger; Deirdre Egan; Catriona Waitt; Mohammed Lamorde; Catherine Orrell; Landon Myer; Saye Khoo; Laura J Else
Journal:  Bioanalysis       Date:  2018-11-19       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.